Seeking Alpha

JNJ
  Johnson & Johnson - NYSE

11/23/2014, 12:31 PM ET
  • Low Sweat Investing | Send Message 6 Oct 2010

    JNJ Buys vaccines co, $2B: "cost-effective growth, limited generic exposure." My article "Can Longtime Dividend Growers Keep Growing?" Aug24
    Reply
      JNJ vs. ETF Alternatives
      Company Description
      Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.